The papers say Louisbourg established this position on the 16th of January. A new claim, a new hope. The price, calculated on the quarter’s average, came to that $5.25 million. It’s a small sum in the grand reckoning of things, but enough to plant a seed and see if it takes root.
Strive Inc. has finalized its acquisition of Semler Scientific, positioning itself as the 11th largest corporate holder of bitcoin. 🧠💸 A transaction as tumultuous as a man gambling with his soul, yet here we are, staring into the abyss of digital gold.
The transaction, dutifully recorded in an SEC filing on January 16th, represents a reduction in Louisbourg’s holding of OR Royalties. The fund retains a respectable 219,271 shares, representing 1.55% of their reported assets under management. One pictures a portfolio manager, not panicking, merely…rebalancing. A tedious exercise, but necessary, especially when dealing with assets that have exhibited a disconcerting tendency to appreciate.
They held 1,069,223 shares. That’s a lot of packaging. It used to be 1.32% of their holdings. Which, honestly, sounds like a remarkably specific amount of faith to place in the structural integrity of boxes. I’ve made less calculated bets on grocery store sushi.
Yes siree. The company that once danced hand-in-hand with lawmakers, singing kumbaya about innovation and financial freedom, turned tail and muttered, “Nah, I don’t like the smell of this one.” And who can blame ‘em? When the fix is in before the game starts, even the most optimistic fool starts checking for aces up the dealer’s sleeve.
The filing says Pictet increased their holdings. Now they have 9,342 shares. The value went up by $3.30 million. Shares and money. They always seem to go together, don’t they? Like loneliness and late-night television. The transaction value, calculated using the average share price over the fourth quarter, was $5.68 million.
The idea, apparently, is diversification. Spreading your money around so when one thing collapses – and something always collapses – you’re not left eating ramen for the rest of your days. It’s a sensible idea, really. Though I suspect most people, myself included, are just delaying the inevitable. Vanguard, this company everyone keeps mentioning, is run by people who seem genuinely committed to… not fleecing you. Which, in this business, is a refreshing change. My broker, on the other hand, owns a yacht. I’m just saying.
The crux of the matter, it seems to me, is this: the adoption of Ripple’s technology does not necessarily translate into a corresponding demand for XRP itself. RippleNet, a system promising swifter, more economical payments, can function quite well utilizing conventional currencies. The banks, those venerable institutions, are perfectly capable of embracing efficiency without succumbing to the allure of the token. It is a subtle point, but a crucial one. One might compare it to a landowner improving his estate with new tools, yet continuing to till the soil in the manner of his fathers.
Indeed, though the stakes have risen higher of late, the grand scheme remains festively draped in clouds of ambiguity! Investors, split as Pascal might say, with one foot in rational expectation and the other in the whimsical abyss of caution born from the latest tremors of correction, hesitate to declare a decisive victory.
Lilly, currently the most richly valued of its kind, announces a partnership – a pact, almost – with Nvidia, the purveyor of these digital oracles. They intend to build a laboratory, a crucible of algorithms, in the heart of Silicon Valley. A billion dollars, they pledge, over five years. A sum that could alleviate immense suffering, or merely accelerate the cycle of speculation. One wonders, does the board truly believe in the promise of AI, or are they simply succumbing to the contagious delirium of the age?